DiDi Global Revenue 2021-2025 | DIDIY
DiDi Global annual/quarterly revenue history and growth rate from 2021 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- DiDi Global revenue for the quarter ending June 30, 2025 was $7.795B, a 10.97% increase year-over-year.
- DiDi Global revenue for the twelve months ending June 30, 2025 was $29.999B, a 8.04% increase year-over-year.
- DiDi Global annual revenue for 2024 was $28.766B, a 6.16% increase from 2023.
- DiDi Global annual revenue for 2023 was $27.096B, a 32.74% increase from 2022.
- DiDi Global annual revenue for 2022 was $20.413B, a 25.17% decline from 2021.
|
DiDi Global Annual Revenue (Millions of US $) |
|
|---|---|
| 2024 | $28,766 |
| 2023 | $27,096 |
| 2022 | $20,413 |
| 2021 | $27,277 |
| 2020 | $21,633 |
|
DiDi Global Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2025-06-30 | $7,795 |
| 2025-03-31 | $7,318 |
| 2024-12-31 | $7,355 |
| 2024-09-30 | $7,531 |
| 2024-06-30 | $7,024 |
| 2024-03-31 | $6,855 |
| 2023-12-31 | $6,787 |
| 2023-09-30 | $7,098 |
| 2023-06-30 | $6,966 |
| 2023-03-31 | $6,244 |
| 2021-09-30 | $6,623 |
| 2021-03-31 | $6,435 |
| 2020-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $26.262B | $28.768B |
| DiDi Global Inc. provides mobility technology platform. It offers app-based services across Asia Pacific, Latin America and Africa as well as in Central Asia and Russia, including ride hailing, taxi hailing, chauffeur, hitch and other forms of shared mobility as well as auto solutions, food delivery, intra-city freight and financial services. DiDi Global Inc. is based in BEIJING. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $154.973B | 28.46 |
| HCA Healthcare (HCA) | United States | $108.075B | 17.89 |
| CVS Health (CVS) | United States | $101.885B | 11.72 |
| Elevance Health (ELV) | United States | $72.812B | 10.68 |
| Cencora (COR) | United States | $70.459B | 22.73 |
| Natera (NTRA) | United States | $28.914B | 0.00 |
| Labcorp Holdings (LH) | United States | $22.051B | 16.81 |
| Medpace Holdings (MEDP) | United States | $16.833B | 41.79 |
| BioMerieux (BMXMF) | France | $15.266B | 0.00 |
| ICON (ICLR) | Ireland | $13.197B | 13.10 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.005B | 0.00 |
| Solventum (SOLV) | United States | $12.806B | 12.43 |
| Viatris (VTRS) | United States | $12.681B | 4.73 |
| CochLear (CHEOY) | Australia | $12.223B | 0.00 |
| Revvity (RVTY) | United States | $10.672B | 19.65 |
| HealthEquity (HQY) | United States | $8.659B | 34.65 |
| Charles River Laboratories (CRL) | United States | $8.440B | 16.26 |
| Avantor (AVTR) | United States | $7.875B | 12.03 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.989B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $6.969B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $6.067B | 36.17 |
| Bausch + Lomb (BLCO) | Canada | $5.880B | 38.60 |
| Sotera Health (SHC) | United States | $4.617B | 22.26 |
| Amplifon S.p.A (AMFPF) | Italy | $4.059B | 23.68 |
| GeneDx Holdings (WGS) | United States | $3.944B | 69.26 |
| Alignment Healthcare (ALHC) | United States | $3.322B | 0.00 |
| Concentras Parent (CON) | United States | $2.558B | 15.97 |
| Premier (PINC) | United States | $2.326B | 22.54 |
| Progyny (PGNY) | United States | $2.075B | 40.80 |
| Surgery Partners (SGRY) | United States | $2.051B | 26.43 |
| Ardent Health (ARDT) | United States | $2.011B | 6.57 |
| Organon (OGN) | United States | $2.004B | 2.11 |
| Pediatrix Medical (MD) | United States | $1.949B | 11.64 |
| Establishment Labs Holdings (ESTA) | $1.836B | 0.00 | |
| PACS (PACS) | United States | $1.747B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.326B | 0.00 |
| Omada Health (OMDA) | $1.242B | 0.00 | |
| GoodRx Holdings (GDRX) | United States | $1.063B | 17.00 |
| Embecta (EMBC) | United States | $0.848B | 4.97 |
| CareDx (CDNA) | United States | $0.839B | 13.71 |
| InnovAge Holding (INNV) | United States | $0.772B | 0.00 |
| Nutex Health (NUTX) | United States | $0.676B | 10.23 |
| AMN Healthcare Services Inc (AMN) | United States | $0.637B | 8.78 |
| Sonida Senior Living (SNDA) | United States | $0.602B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.562B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| Pomdoctor - (POM) | China | $0.457B | 0.00 |
| CryoPort (CYRX) | United States | $0.442B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.417B | 0.00 |
| Enhabit (EHAB) | United States | $0.407B | 18.30 |
| Auna S.A (AUNA) | Luxembourg | $0.387B | 5.81 |
| So-Young (SY) | China | $0.378B | 0.00 |
| SBC Medicals (SBC) | United States | $0.351B | 7.68 |
| Oncology Institute (TOI) | United States | $0.321B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.305B | 0.00 |
| KindlyMD (NAKA) | United States | $0.295B | 0.00 |
| Agilon Health (AGL) | United States | $0.260B | 0.00 |
| LifeMD (LFMD) | United States | $0.240B | 0.00 |
| Beauty Health (SKIN) | United States | $0.169B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.157B | 26.99 |
| Ascend Wellness Holdings (AAWH) | United States | $0.137B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.118B | 0.00 |
| DocGo (DCGO) | United States | $0.106B | 0.00 |
| Biodesix (BDSX) | United States | $0.063B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.049B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.026B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.024B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 5.58 |
| SeaStar Medical Holding (ICU) | United States | $0.017B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| ISpecimen (ISPC) | United States | $0.006B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |